[144] ORACLE CORP SEC Filing

Rhea-AI Filing Summary

ORCL Form 144 filing shows a proposed sale of 2,222 common shares through Fidelity Brokerage Services on 09/26/2025 with an aggregate market value of $641,958.24. The shares were acquired on 05/31/2022 by restricted stock vesting and were received as compensation. The filing also discloses that Naomi Seligman sold 3,303 common shares on 07/16/2025 for $770,656.29. The issuer's outstanding shares are listed as 2,841,714,000, indicating these transactions are small relative to total shares outstanding.

Positive

• Rule 144 disclosure provided with acquisition details and planned sale date, supporting regulatory compliance

Negative

• None.

Insights

Financial Analyst

TL;DR: Insider sale is disclosed; size is immaterial versus total outstanding shares, so limited market impact.

The filing documents a Rule 144 notice for 2,222 shares valued at $641,958.24 to be sold via Fidelity on 09/26/2025. The shares were acquired through restricted stock vesting on 05/31/2022 as compensation. A prior sale by the same person on 07/16/2025 of 3,303 shares for $770,656.29 is also reported. Given the issuer's stated 2.84 billion shares outstanding, these transactions represent an extremely small percentage of the float and are unlikely to materially affect liquidity or valuation.

Corporate Governance Expert

TL;DR: The filer follows Rule 144 disclosure; documentation supports compliance but reveals routine insider monetization.

The notice includes required acquisition details, showing the 2,222 shares stem from restricted stock vesting and were paid as compensation, which clarifies insider ownership provenance. The signature declaration affirms no undisclosed material adverse information. The reportability and timing satisfy standard disclosure expectations; there is no evidence in this filing of unusual governance or compliance concerns.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	2222	641958.24	2841714000	09/26/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	05/31/2022	Restricted Stock Vesting	Issuer			2222	05/31/2022	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Naomi Seligman 2300 Oracle Way Austin TX 78741	Common	07/16/2025	3303	770656.29

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does ORCL's Form 144 filed here disclose?

The filing discloses a proposed sale of 2,222 common shares via Fidelity on 09/26/2025 valued at $641,958.24.

Who acquired the shares and how were they acquired?

The 2,222 shares were acquired on 05/31/2022 through restricted stock vesting and were received as compensation.

Did the filer sell any shares recently?

Yes. Naomi Seligman sold 3,303 common shares on 07/16/2025 for gross proceeds of $770,656.29.

How large are these transactions relative to Oracle's outstanding shares?

The filing lists 2,841,714,000 shares outstanding, so the 2,222-share notice is immaterial as a percentage of total outstanding shares.

Does the filing indicate any undisclosed material information about Oracle?

By signing the notice the person represents they do not know any material adverse information about the issuer that is not publicly disclosed.